Downloads
Title
Source name
Date

Roche's Vabysmo shows no sign of slowdown after Regeneron and Bayer's launch of Eylea HD

Roche's Vabysmo shows no sign of slowdown after Regeneron and Bayer's launch of Eylea HD kdunleavy Wed, 04/24/2024 - 10:58

FiercePharma
24 Apr 2024

Biogen 'turning the corner' as Leqembi and Skyclarys launches advance, but much work remains to be done: CEO

Biogen 'turning the corner' as Leqembi and Skyclarys launches advance, but much work remains to be done: CEO fkansteiner Wed, 04/24/2024 - 11:26

FiercePharma
24 Apr 2024

Chiesi survey shows how Fabry drugs are failing patients, providing road map for ousting incumbents

Chiesi survey shows how Fabry drugs are failing patients, providing road map for ousting incumbents ntaylor Wed, 04/24/2024 - 09:48

FiercePharma
24 Apr 2024

AbbVie starts open casting call for next faces of Botox ads, doubling down on pitch to everyday users

AbbVie starts open casting call for next faces of Botox ads, doubling down on pitch to everyday users ntaylor Wed, 04/24/2024 - 06:04

FiercePharma
24 Apr 2024

AstraZeneca and Merck's Lynparza set to 'dominate' PARP market as it looks to grow cancer offerings with 100-plus ongoing trials

AstraZeneca and Merck's Lynparza set to 'dominate' PARP market as it looks to grow cancer offerings with 100-plus ongoing trials badams Wed, 04/24/2024 - 04:52

FiercePharma
24 Apr 2024

Vertex jumps to TreeFrog to enhance production of Type 1 diabetes cell therapy candidates

Vertex jumps to TreeFrog to enhance production of Type 1 diabetes cell therapy candidates kdunleavy Tue, 04/23/2024 - 16:40

FiercePharma
24 Apr 2024

Orphan drug market to reach $270B by 2028, led by J&J, Vertex and Roche: Evaluate

Orphan drug market to reach $270B by 2028, led by J&J, Vertex and Roche: Evaluate zbecker Tue, 04/23/2024 - 17:34

FiercePharma
24 Apr 2024

Day One takes on Novartis with FDA nod for Ojemda in broader common childhood brain tumor use

Day One takes on Novartis with FDA nod for Ojemda in broader common childhood brain tumor use aliu Tue, 04/23/2024 - 22:15

FiercePharma
24 Apr 2024

Novartis dials up 2024 sales outlook, preps for key expansions of 3 cancer drugs

Novartis dials up 2024 sales outlook, preps for key expansions of 3 cancer drugs aliu Tue, 04/23/2024 - 15:46

FiercePharma
24 Apr 2024

Eli Lilly inks deal to acquire Nexus manufacturing plant in Wisconsin as Mounjaro and Zepbound shortages drag on

Eli Lilly inks deal to acquire Nexus manufacturing plant in Wisconsin as Mounjaro and Zepbound shortages drag on fkansteiner Tue, 04/23/2024 - 15:10

FiercePharma
24 Apr 2024

New kid on The Bloc: Ogilvy, McCann alum Eduardo Basque joins as associate creative director

New kid on The Bloc: Ogilvy, McCann alum Eduardo Basque joins as associate creative director apark Tue, 04/23/2024 - 11:25

FiercePharma
24 Apr 2024

Another delay for Abeona's topical gene therapy pz-cel as FDA sends out a rejection

Another delay for Abeona's topical gene therapy pz-cel as FDA sends out a rejection kdunleavy Tue, 04/23/2024 - 11:04

FiercePharma
24 Apr 2024

Novartis 'actively' reviewing relationships with Chinese contractors amid US biosecurity crackdown: CFO

Novartis 'actively' reviewing relationships with Chinese contractors amid US biosecurity crackdown: CFO fkansteiner Tue, 04/23/2024 - 11:10

FiercePharma
24 Apr 2024

Life sci consulting firm Santander launches with offer of commercial strategy guidance

Life sci consulting firm Santander launches with offer of commercial strategy guidance apark Tue, 04/23/2024 - 10:27

FiercePharma
24 Apr 2024

Leqembi launch hamstrung by physicians' 'therapeutic nihilism'

Leqembi launch hamstrung by physicians' 'therapeutic nihilism' ntaylor Tue, 04/23/2024 - 09:32

FiercePharma
24 Apr 2024

'Like a homecoming': Inizio Evoke Comms welcomes back alum Stephanie DeViteri as North American president

'Like a homecoming': Inizio Evoke Comms welcomes back alum Stephanie DeViteri as North American president apark Mon, 04/22/2024 - 16:52

FiercePharma
23 Apr 2024

Novartis nominates former Bristol Myers CEO Giovanni Caforio as its new chair. Will M&A deals follow?

Novartis nominates former Bristol Myers CEO Giovanni Caforio as its new chair. Will M&A deals follow? aliu Tue, 04/23/2024 - 03:00

FiercePharma
23 Apr 2024

Patrick Soon-Shiong's ImmunityBio bags FDA approval for Anktiva to challenge Merck in bladder cancer

Patrick Soon-Shiong's ImmunityBio bags FDA approval for Anktiva to challenge Merck in bladder cancer aliu Mon, 04/22/2024 - 16:19

FiercePharma
23 Apr 2024

US Supreme Court rejects Vanda's bid to revive patents on sleep disorder drug Hetlioz

US Supreme Court rejects Vanda's bid to revive patents on sleep disorder drug Hetlioz fkansteiner Mon, 04/22/2024 - 14:44

FiercePharma
23 Apr 2024

Sanofi's Zantac settlement is worth $100M, or $25K per claimant: Bloomberg

Sanofi's Zantac settlement is worth $100M, or $25K per claimant: Bloomberg kdunleavy Mon, 04/22/2024 - 14:13

FiercePharma
23 Apr 2024

With $380M deal, Bristol Myers Squibb ups the ante with cell therapy manufacturer Cellares

With $380M deal, Bristol Myers Squibb ups the ante with cell therapy manufacturer Cellares kdunleavy Mon, 04/22/2024 - 10:44

FiercePharma
23 Apr 2024

Ahead of Alnylam's key heart disease readout, experts say Pfizer rival would be hard to displace

Ahead of Alnylam's key heart disease readout, experts say Pfizer rival would be hard to displace aliu Mon, 04/22/2024 - 10:27

FiercePharma
23 Apr 2024

Endo's Par Pharma issues recall of blood pressure med over possible contamination

Endo's Par Pharma issues recall of blood pressure med over possible contamination jkeenan Mon, 04/22/2024 - 09:53

FiercePharma
23 Apr 2024

3 Principles to Optimize Patient Support Programs

3 Principles to Optimize Patient Support Programs jpiatt Mon, 04/15/2024 - 15:58

FiercePharma
23 Apr 2024

FibroGen, former employees settle dispute over alleged trade secrets theft

FibroGen, former employees settle dispute over alleged trade secrets theft fkansteiner Fri, 04/19/2024 - 11:46

FiercePharma
23 Apr 2024
We use cookies to enhance your browsing experience. By continuing to use our website you agree to our policies Read the policyAccept